| Concordia Life Plan Community | |
|
7707 W Britton Rd Oklahoma City OK 73132-1512 | |
| (405) 720-7200 | |
| (405) 621-8701 |
| Full Name | Concordia Life Plan Community |
|---|---|
| Speciality | Nurse Practitioner |
| Location | 7707 W Britton Rd, Oklahoma City, Oklahoma |
| Authorized Official Name and Position | Daniel Eischen (CHIEF OPERATING OFFICER) |
| Authorized Official Contact | 4057207200 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Concordia Life Plan Community 7707 W Britton Rd Oklahoma City OK 73132-1512 Ph: (405) 720-7200 | Concordia Life Plan Community 7707 W Britton Rd Oklahoma City OK 73132-1512 Ph: (405) 720-7200 |
| NPI Number | 1043814023 |
|---|---|
| Provider Enumeration Date | 11/30/2020 |
| Last Update Date | 11/30/2020 |
| Medicare PECOS PAC ID | 7416026802 |
|---|---|
| Medicare Enrollment ID | O20210114002526 |
News Archive
A team of researchers from leading universities in Turkey and the United States have reported that they have identified the genetic mutation responsible for the Uner Tan Syndrome (UTS) using advanced genetic capture and sequencing technologies from Roche. The combined genomic technologies enabled the team of scientists to identify the causative mutation of this debilitating disease after years of mystery.
Obese and overweight workers are more likely to incur high costs related to workers' compensation claims for major injuries, reports a study in the September Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
Mailing yearly stool kits-an alternative to the often-dreaded colonoscopy-has helped Group Health to boost rates of lifesaving screening for colon cancer, according to new research from Group Health Research Institute.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
Research by University of Iowa virologist Wendy Maury, PhD, has helped facilitate the launch of a new clinical trial in the United Kingdom of a drug that might help treat patients with COVID-19.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043814023 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 363L00000X | Nurse Practitioner | (* (Not Available)) | Primary |
| Provider Name | Courtney W Hammond |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992938450 PECOS PAC ID: 1355488669 Enrollment ID: I20091019000535 |
News Archive
A team of researchers from leading universities in Turkey and the United States have reported that they have identified the genetic mutation responsible for the Uner Tan Syndrome (UTS) using advanced genetic capture and sequencing technologies from Roche. The combined genomic technologies enabled the team of scientists to identify the causative mutation of this debilitating disease after years of mystery.
Obese and overweight workers are more likely to incur high costs related to workers' compensation claims for major injuries, reports a study in the September Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
Mailing yearly stool kits-an alternative to the often-dreaded colonoscopy-has helped Group Health to boost rates of lifesaving screening for colon cancer, according to new research from Group Health Research Institute.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
Research by University of Iowa virologist Wendy Maury, PhD, has helped facilitate the launch of a new clinical trial in the United Kingdom of a drug that might help treat patients with COVID-19.
› Verified 2 days ago
News Archive
A team of researchers from leading universities in Turkey and the United States have reported that they have identified the genetic mutation responsible for the Uner Tan Syndrome (UTS) using advanced genetic capture and sequencing technologies from Roche. The combined genomic technologies enabled the team of scientists to identify the causative mutation of this debilitating disease after years of mystery.
Obese and overweight workers are more likely to incur high costs related to workers' compensation claims for major injuries, reports a study in the September Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
Mailing yearly stool kits-an alternative to the often-dreaded colonoscopy-has helped Group Health to boost rates of lifesaving screening for colon cancer, according to new research from Group Health Research Institute.
DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.
Research by University of Iowa virologist Wendy Maury, PhD, has helped facilitate the launch of a new clinical trial in the United Kingdom of a drug that might help treat patients with COVID-19.
› Verified 2 days ago
Oklahoma Mental Health Council Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4420 N Lincoln Blvd, Oklahoma City, OK 73105 Phone: 405-424-7711 | |
American Current Care P.a. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7100 S I-35 Service Road, Suite 7, Oklahoma City, OK 73149 Phone: 405-632-1002 Fax: 405-632-3131 | |
St Anthony Primary Care Physicians North Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6201 N Santa Fe Ave, Suite 2020, Oklahoma City, OK 73118 Phone: 405-272-5433 Fax: 405-272-5435 | |
Oklahoma Pain & Rehab Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2149 Sw 59th St, Suite 201, Oklahoma City, OK 73119 Phone: 405-681-5800 | |
Board Of Regents Of The Univ Of Okla Ou Physicians Employer Spons Clin Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 N Robinson Ave, Suite 200, Oklahoma City, OK 73102 Phone: 405-271-8880 Fax: 405-208-8732 | |
St Anthony North Urgent Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6201 N Santa Fe Ave, Suite 1010, Oklahoma City, OK 73118 Phone: 405-772-8687 Fax: 405-772-8688 | |
Barreto Health Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3418 Nw 135th St, Oklahoma City, OK 73120 Phone: 405-286-1075 Fax: 405-608-1075 |